← Evidence map

ReviewFrontiers in immunology2022

Neoadjuvant immunotherapy for resectable esophageal cancer: A review.

Qing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

44 papers cite it

2022
2023
2024
2025
2026
this paperpooled ittrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 36569908